Clinical Trials in Nashville

Showing 9161-9180 of 20,298 trials

Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism

NCT03847337

In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening tools. The investigators want to see if they are good at identifying children with ASD and children without ASD. The investigators hope this research will make it easier for families to get answers when there are concerns for ASD.

Autism Spectrum DisorderDevelopmental Delay

Vanderbilt University Medical Center144 participantsStarted Mar 2019

Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

NCT03980041

The purpose of this study is to measure the effect of IPI-549 in combination with nivolumab when compared to nivolumab monotherapy in advanced urothelial cancer patients.

Bladder CancerUrothelial CarcinomaSolid Tumor+1 more

Infinity Pharmaceuticals, Inc.49 participantsStarted Sep 2019

Fort Wayne, Indiana, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +26 more locations

Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Find Trials by Condition in Nashville

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary Dysmenorrhea